drug · antibody
patient view →KESIMPTA
Marketedupdated 2mo agoby $NVS NOVARTIS AG🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 17 investigational indications.
targets
B-lymphocyte antigen CD20
all catalysts(13)
approval · 13
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that